{
    "title": "Biogen gears up for potential launch of Alzheimer's drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7947303/Biogen-beats-profit-estimates-demand-multiple-sclerosis-drug.html",
    "date": "2020-01-30",
    "keywords": [
        "biogen",
        "drug",
        "treatment",
        "company",
        "share",
        "launch",
        "approval",
        "roy",
        "tamara",
        "market",
        "aducanumab",
        "development",
        "revenue",
        "trial",
        "quarter",
        "profit",
        "inc",
        "thursday",
        "drugmaker",
        "memoryrobbing",
        "disease",
        "application",
        "time",
        "reversal",
        "analysis",
        "focus",
        "officer",
        "michel",
        "vounatsos",
        "conference",
        "call",
        "age",
        "level",
        "engagement",
        "food",
        "administration",
        "executive",
        "vice",
        "president",
        "research",
        "matter",
        "documentation",
        "force",
        "analyst",
        "michael",
        "opinion",
        "panel",
        "fda",
        "class",
        "growth",
        "sclerosis",
        "threat",
        "patent",
        "competition",
        "fullyear",
        "reporting",
        "trisha",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}